Skip to main content
What types of page to search?

Alternatively use our A-Z index.

World Immunisation Week 2026

A scientist is working in a lab handling liquid samples

Pioneering vaccine research across the globe.

Vaccines are one of the most powerful tools we have to prevent disease and save lives, and our research is shaping their future on a global scale. Building on decades of expertise, our research has contributed to vaccines that protect millions worldwide, from emerging viral threats to persistent global health challenges.

Transformative capabilities

We combine cutting-edge platform technologies with a One Health approach, enabling us to address diseases affecting both people and animals. From early-stage discovery through to clinical trials, regulatory engagement, and implementation, we deliver end-to-end vaccine innovation.

As new health challenges emerge, we are driving the next generation of vaccines that are faster to develop, easier to deliver, and accessible to those who need them most.

Discover our impact

Someone holding a test tube filled with blood. the test tube has

Building resilience for zika outbreaks

A vaccine breakthrough that could protect unborn children from the most severe consequences of Zika.

A doctor is holding a child in her arms as they pose for a photograph

Tackling typhoid fever

A landmark trial in Malawi has helped drive global efforts to prevent typhoid.

Gloved hands are holding a syringe and a vial to extract liquid

Surveillance of mpox vaccine

Study led by Liverpool researchers reveals that mpox vaccine generates immune response to emerging strains.

A gloved hand is holding a vial labelled

Expertise in vaccine evaluation

A Liverpool dose-finding trial shows a neonatal rotavirus vaccine can deliver a robust immune response in newborns.

Gloved hands are applying a plaster to a child's arm after a vaccination injection

Making best use of vaccines

Supporting the House of Lords inquiry into declining childhood vaccination rates.

A scanning electron micrograph depicting Streptococcus pyogenes bacteria

Pioneering bacterial vaccines

ReNewVax is a University of Liverpool spin-out which aims to develop the first universal vaccine against all pneumococcal infections.